Carregant...

Rapidly fatal advanced EGFR-mutated lung cancers and the need for rapid tumor genotyping in clinical practice

Use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is associated with dramatic, durable, and tolerable responses and side effect profiles when applied for palliation of advanced EGFR-mutated non-small-cell lung cancers (NSCLCs). Expert guidelines recommend that EGFR mut...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Treat Commun
Autors principals: Rangachari, Deepa, Drake, Lauren, Huberman, Mark S., McDonald, Danielle C., VanderLaan, Paul A., Folch, Erik, Costa, Daniel B.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5241076/
https://ncbi.nlm.nih.gov/pubmed/28111612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctarc.2016.07.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!